摘要
目的:观察复方福尔可定对慢性阻塞性肺疾病(COPD)急性发作的止咳、化痰效果。方法:50例COPD急性加重期患者,除常规抗炎、止喘、祛痰等治疗外,加复方福尔可定10ml,4次/日,口服治疗作为主要止咳、化痰药。48例COPD急性加重患者作为对照。结果:加用复方福尔可定治疗止咳化痰效果显著,咳嗽症状病程缩短。结论:复方福尔可定可作为COPD急性期常规止咳、化痰主要药物。
Objective：To observe the effect of Compound Pholcodine Oral Solution （CPOS） for treating C OPD. Methods：50 patients with acute exacerbation phase of COPD,were not only treated by anti-inflammatory, anti-asthmatic and expelling phlegm drugs, but also given CPOS 10 ml,4times/d as a most important drug. 48 patients with acute exacerbation phase of COPD were as controls. Results： Compound Pholcodine Oral Solution had a better effect on anti-asthmatic and expelling phlegm and shortened the cough time. Conclu- sion：Compound Pholcodine Oral Solution is a main drug in treating acute exacerbation phase of COPD.
出处
《现代医药卫生》
2009年第9期1318-1319,共2页
Journal of Modern Medicine & Health
